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What is 
prescription 
drug abuse? 
from the director:
The nonmedical use and abuse of 
prescription drugs is a serious public 
health problem in this country. Although 
most people take prescription medications 
responsibly, an estimated 52 million 
people (20 percent of those aged 12 and 
older) have used prescription drugs for 
nonmedical reasons at least once in 
their lifetimes. Young people are strongly 
represented in this group. In fact, the 
National Institute on Drug Abuse’s (NIDA) 
Monitoring the Future (MTF) survey found 
that about 1 in 12 high school seniors 
reported past-year nonmedical use of 
the prescription pain reliever Vicodin 
in 2010, and 1 in 20 reported abusing 
OxyContin—making these medications 
among the most commonly abused drugs 
by adolescents. 
The abuse of certain prescription drugs—
opioids, central nervous system (CNS) 
depressants, and stimulants—can lead 
to a variety of adverse health effects, 
including addiction. Among those who 
reported past-year nonmedical use of a 
prescription drug, nearly 14 percent met 
criteria for abuse of or dependence on 
it. The reasons for the high prevalence 
of prescription drug abuse vary by age, 
gender, and other factors, but likely 
include greater availability. 
The number of prescriptions for some 
of these medications has increased 
dramatically since the early 1990s (see 
figures, page 2). Moreover, a consumer 
culture amenable to “taking a pill for 
what ails you” and the perception of 
prescription drugs as less harmful than 
illicit drugs are other likely contributors 
to the problem. It is an urgent one: 
unintentional overdose deaths involving 
opioid pain relievers have quadrupled 
since 1999, and by 2007, outnumbered 
those involving heroin and cocaine. 
NIDA hopes to change this situation by 
increasing awareness and promoting 
additional research on prescription drug 
abuse. Prescription drug abuse is not 
a new problem, but one that deserves 
renewed attention. It is imperative that as 
a Nation we make ourselves aware of the 
consequences associated with abuse of 
these medications. 
Nora D. Volkow, M.D. 
Director 
National Institute on Drug Abuse 
Preventing and 
recognizing 
prescription  
drug abuse
See page 10.
Prescription drug abuse1 is the use of a medication without a prescription, in a way other than as prescribed, or for the experience or feelings elicited. According to several 
national surveys, prescription medications, such as those used to 
treat pain, attention deficit disorders, and anxiety, are being abused 
at a rate second only to marijuana among illicit drug users.  The 
consequences of this abuse have been steadily worsening, reflected 
in increased treatment admissions, emergency room visits, and 
overdose deaths.
continued inside
Prescription 
Drug Abuse
1 Prescription drug abuse, as defined in this report, is equivalent to the term “nonmedical 
use,” used by many of the national surveys or data collection systems. This definition does not 
correspond to the definition of abuse/dependence listed in the Diagnostic and Statistical Manual of 
Mental Disorders, 4th edition (DSM-IV).
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What are some 
of the commonly 
abused 
prescription 
drugs? 
Although many medications can be 
abused, the following three classes 
are most commonly abused:
• Opioids—usually prescribed to 
treat pain; 
• Central nervous system (CNS) 
depressants—used to treat anxiety 
and sleep disorders; and 
• Stimulants—most often 
prescribed to treat attention-deficit 
hyperactivity disorder (ADHD).
Opioids—
What are opioids? 
Opioids are medications that relieve 
pain. They reduce the intensity of 
pain signals reaching the brain and 
affect those brain areas controlling 
emotion, which diminishes the 
effects of a painful stimulus. 
Medications that fall within this class 
include hydrocodone (e.g., Vicodin), 
oxycodone (e.g., OxyContin, 
Percocet), morphine (e.g., Kadian, 
Avinza), codeine, and related drugs. 
Hydrocodone products are the most 
commonly prescribed for a variety of 
painful conditions, including dental 
and injury-related pain. Morphine is 
often used before and after surgical 
procedures to alleviate severe pain. 
Codeine, on the other hand, is often 
0
50
100
150
200
250
Total Number of Opioid Prescriptions 
Dispensed by U.S. Retail Pharmacies, 
1991–2010
Source: SDI’s Vector One®: National (VONA)
91 92 93 94 95 96 97 98 00 01 02 03 04 05 06 07 08 09 99
Number of Opioid Rxs
Hydrocodone
Oxycodone
76 78 80
86 91
96 100
109
120
131
139
144
151
158
169
180
192
201 202
N
um
be
r o
f P
re
sc
rip
tio
ns
 (m
ill
io
ns
)
10
210
2 NIDA Research Report Series
Prescription 
Drug Abuse
who abuse opioids may seek to 
intensify their experience by taking 
the drug in ways other than those 
prescribed. For example, OxyContin 
is an oral medication used to treat 
moderate to severe pain through a 
slow, steady release of the opioid. 
People who abuse OxyContin may 
snort or inject it,2 thereby increasing 
their risk for serious medical 
complications, including overdose.
What are the possible 
consequences of opioid 
use and abuse? 
Taken as prescribed, opioids can 
be used to manage pain safely and 
effectively. However, when abused, 
even a single large dose can cause 
severe respiratory depression 
and death. Properly managed, 
short-term medical use of opioid 
analgesics rarely causes addiction—
characterized by compulsive drug 
seeking and use despite serious 
adverse consequences. Regular 
(e.g., several times a day, for several 
weeks or more) or longer term use or 
abuse of opioids can lead to physical 
dependence and, in some cases, 
addiction. Physical dependence 
is a normal adaptation to chronic 
exposure to a drug and is not the 
same as addiction (see text box on 
“Dependence vs. Addiction” on 
page 3). In either case, withdrawal 
symptoms may occur if drug use is 
suddenly reduced or stopped.  These 
symptoms can include restlessness, 
muscle and bone pain, insomnia, 
diarrhea, vomiting, cold flashes with 
goose bumps (“cold turkey”), and 
involuntary leg movements.   
prescribed for mild pain. In addition 
to their pain-relieving properties, 
some of these drugs—codeine 
and diphenoxylate (Lomotil) for 
example—can be used to relieve 
coughs and severe diarrhea. 
How do opioids affect 
the brain and body? 
Opioids act by attaching to specific 
proteins called opioid receptors, 
which are found in the brain, spinal 
cord, gastrointestinal tract, and other 
organs in the body. When these drugs 
attach to their receptors, they reduce 
the perception of pain. Opioids can 
also produce drowsiness, mental 
confusion, nausea, constipation, 
and, depending upon the amount of 
drug taken, can depress respiration. 
Some people experience a euphoric 
response to opioid medications, since 
these drugs also affect the brain 
regions involved in reward. Those 
2 Changing the route of administration also contributes to the abuse of other prescription medications, including stimulants, a practice that can lead to 
serious medical consequences.
 
Physical dependence occurs because of normal adaptations to 
chronic exposure to a drug and is not the same as addiction. 
Addiction, which can include physical dependence, is distinguished 
by compulsive drug seeking and use despite sometimes 
devastating consequences.
Someone who is physically dependent on a medication will 
experience withdrawal symptoms when use of the drug is abruptly 
reduced or stopped. These symptoms can be mild or severe 
(depending on the drug) and can usually be managed medically or 
avoided by using a slow drug taper.
Dependence is often accompanied by tolerance, or the need to take 
higher doses of a medication to get the same effect. When tolerance 
occurs, it can be difficult for a physician to evaluate whether a 
patient is developing a drug problem, or has a real medical need for 
higher doses to control their symptoms. For this reason, physicians 
need to be vigilant and attentive to their patients’ symptoms and 
level of functioning to treat them appropriately.
Dependence vs. Addiction 
In 2007, the number of overdose deaths from 
prescription opioids outnumbered deaths 
from heroin and cocaine combined.
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Is it safe to use opioid drugs 
with other medications? 
Only under a physician’s supervision 
can opioids be used safely with 
other drugs. Typically, they 
should not be used with other 
substances that depress the CNS, 
such as alcohol, antihistamines, 
barbiturates, benzodiazepines, 
or general anesthetics, because 
these combinations increase the 
risk of life-threatening respiratory 
depression.
CNS 
depressants—
What are CNS depressants?  
CNS depressants, sometimes referred 
to as sedatives and tranquilizers, 
are substances that can slow brain 
activity. This property makes them 
useful for treating anxiety and sleep 
disorders. Among the medications 
commonly prescribed for these 
purposes are the following: 
• Benzodiazepines, such 
as diazepam (Valium) and 
alprazolam (Xanax), are 
sometimes prescribed to treat 
anxiety, acute stress reactions, 
and panic attacks. The more 
sedating benzodiazepines, such as 
triazolam (Halcion) and estazolam 
(ProSom) are prescribed for short-
term treatment of sleep disorders. 
Usually, benzodiazepines are 
not prescribed for long-term use 
because of the risk for developing 
tolerance, dependence, or 
addiction. 
• Non-benzodiazepine sleep 
medications, such as zolpidem 
(Ambien), eszopiclone (Lunesta), 
and zalepon (Sonata), have a 
different chemical structure, but 
act on some of the same brain 
receptors as benzodiazepines. 
OxyContin 
and heroin 
have similar 
chemical 
structures and 
bind to the 
same receptors 
in the brain.
 
While the relationship between opioid overdose and depressed 
respiration (slowed breathing) has been confirmed, researchers are 
also studying the long-term effects on brain function. Depressed 
respiration can affect the amount of oxygen that reaches the brain, 
a condition called hypoxia. Hypoxia can have short- and long-
term psychological and neurological effects, including coma and 
permanent brain damage.
Researchers are also investigating the long-term effects of opioid 
addiction on the brain. Studies have shown some deterioration 
of the brain’s white matter due to heroin use, which may affect 
decision-making abilities, the ability to regulate behavior, and 
responses to stressful situations.
Opioids and Brain Damage
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develops, these side effects begin to 
disappear. If one uses these drugs 
long term, larger doses may be 
needed to achieve the therapeutic 
effects. Continued use can also 
lead to physical dependence and 
withdrawal when use is abruptly 
reduced or stopped  (see text box 
on “Dependence vs. Addiction” 
on page 3). Because all CNS 
depressants work by slowing the 
brain’s activity, when an individual 
stops taking them, there can be a 
rebound effect, resulting in seizures 
or other harmful consequences. 
Although withdrawal from 
benzodiazepines can be problematic, 
it is rarely life threatening, whereas 
withdrawal from prolonged use of 
barbiturates can have life-threatening 
complications. Therefore, someone 
who is thinking about discontinuing 
CNS depressant therapy or who is 
suffering withdrawal from a CNS 
depressant should speak with a 
physician or seek immediate  
medical treatment. 
Is it safe to use CNS 
depressants with other 
medications? 
Only under a physician’s supervision 
is it safe to use CNS depressants 
with other medications. Typically, 
they should not be combined with 
any other medication or substance 
that causes CNS depression, 
including prescription pain 
medicines, some OTC cold and 
allergy medications, and alcohol. 
Using CNS depressants with these 
other substances—particularly 
alcohol—can affect heart rhythm, 
slow respiration, and even lead  
to death.
They are thought to have 
fewer side effects and less 
risk of dependence than 
benzodiazepines.
• Barbiturates, such as 
mephobarbital (Mebaral), 
phenobarbital (Luminal Sodium), 
and pentobarbital sodium 
(Nembutal), are used less 
frequently to reduce anxiety or to 
help with sleep problems because 
of their higher risk of overdose 
compared to benzodiazepines. 
However, they are still used 
in surgical procedures and for 
seizure disorders. 
How do CNS depressants 
affect the brain and body? 
Most CNS depressants act 
on the brain by affecting the 
neurotransmitter gamma-
aminobutyric acid (GABA). 
Neurotransmitters are brain 
chemicals that facilitate 
communication between brain cells. 
Although the different classes of 
CNS depressants work in unique 
ways, it is through their ability to 
increase GABA—and thereby inhibit 
brain activity—that they produce a 
drowsy or calming effect beneficial 
to those suffering from anxiety or 
sleep disorders. 
What are the possible 
consequences of CNS 
depressant use and abuse? 
Despite their many beneficial effects, 
benzodiazepines and barbiturates 
have the potential for abuse and 
should be used only as prescribed. 
The use of non-benzodiazepine 
sleep aids is less well studied, 
but certain indicators have raised 
concern about their abuse liability 
as well. During the first few 
days of taking a prescribed CNS 
depressant, a person usually feels 
sleepy and uncoordinated, but as 
the body becomes accustomed to 
the effects of the drug and tolerance 
 
Over-the-counter (OTC) medications, such as certain cough 
suppressants, sleep aids, and antihistamines, can be abused for 
their psychoactive effects. This typically means taking doses higher 
than recommended or combining OTC medications with alcohol, or 
with illicit or prescription drugs. Either practice can have dangerous 
results, depending on the medications involved. Some contain 
aspirin or acetaminophen (e.g., Tylenol), which can be toxic to the 
liver at high doses. Others, when taken for their “hallucinogenic” 
properties, can cause confusion, psychosis, coma, and even death. 
Cough syrups and cold medications are the most commonly 
abused OTC medications. In 2010, for example, 6.6 percent of high 
school seniors took cough syrup ”to get high.” At high doses, 
dextromethorphan—a key ingredient found in cough syrup—can 
act like PCP or ketamine, producing dissociative or out-of-body 
experiences. 
Over-the-Counter Medicines 
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The dramatic increases in stimulant prescriptions over the last 2 
decades have led to their greater environmental availability and 
increased risk for diversion and abuse. For those who take these 
medications to improve properly diagnosed conditions, they 
can be transforming, greatly enhancing a person’s quality of life. 
However, because they are perceived by many to be generally 
safe and effective, prescription stimulants, such as Concerta or 
Adderall, are increasingly being abused to address nonmedical 
conditions or situations. Indeed, reports suggest that the practice 
is occurring among some academic professionals, athletes, 
performers, older people, and both high school and college 
students. Such nonmedical cognitive enhancement poses 
potential health risks, including addiction, cardiovascular events, 
and psychosis. 
Cognitive Enhancers 
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Stimulants—
What are stimulants?
As the name suggests, stimulants 
increase alertness, attention, and 
energy, as well as elevate blood 
pressure, heart rate, and respiration. 
Stimulants historically were used to 
treat asthma and other respiratory 
problems, obesity, neurological 
disorders, and a variety of other 
ailments. But as their potential 
for abuse and addiction became 
apparent, the medical use of 
stimulants began to wane. Now, 
stimulants are prescribed to treat 
only a few health conditions, 
including ADHD, narcolepsy, and 
occasionally depression—in those 
who have not responded to other 
treatments. 
How do stimulants affect 
the brain and body?  
Stimulants, such as 
dextroamphetamine (Dexedrine 
and Adderall) and methylphenidate 
(Ritalin and Concerta), act in the 
brain similarly to a family of key 
brain neurotransmitters called 
monoamines, which include 
norepinephrine and dopamine. 
Stimulants enhance the effects of 
these chemicals in the brain. The 
associated increase in dopamine can 
induce a feeling of euphoria when 
stimulants are taken nonmedically. 
Stimulants also increase blood 
pressure and heart rate, constrict 
blood vessels, increase blood 
glucose, and open up breathing 
passages.
Youth who abuse prescription medications are 
also more likely to report use of other drugs. 
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What are the possible 
consequences of stimulant 
use and abuse?  
As with other drugs of abuse, it is 
possible for individuals to become 
dependent upon or addicted to 
stimulants. Withdrawal symptoms 
associated with discontinuing 
stimulant use include fatigue, 
depression, and disturbance of sleep 
patterns. Repeated abuse of some 
stimulants (sometimes within a 
short period) can lead to feelings of 
hostility or paranoia, even psychosis. 
Further, taking high doses of a 
stimulant may result in dangerously 
high body temperature and an 
irregular heartbeat. There is also the 
potential for cardiovascular failure or 
seizures. 
Is it safe to use stimulants 
with other medications? 
Stimulants should not be used with 
other medications unless authorized 
by a physician. Patients also should 
be aware of the dangers associated 
with mixing stimulants and OTC cold 
medicines that contain decongestants, 
as combining these substances may 
cause blood pressure to become 
dangerously high or lead to irregular 
heart rhythms.
 
Trends in 
prescription 
drug abuse 
How many people abuse 
prescription drugs? 
According to results from the 2010 
National Survey on Drug Use and 
Health (NSDUH), an estimated 2.4 
million Americans used prescription 
drugs nonmedically for the first time 
within the past year, which averages 
to approximately 6,600 initiates 
per day. More than one-half were 
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Youth who abuse prescription 
medications are also more likely to 
report use of other drugs. Multiple 
studies have revealed associations 
between prescription drug abuse and 
higher rates of cigarette smoking; 
heavy episodic drinking; and 
marijuana, cocaine, and other illicit 
drug use among adolescents, young 
adults, and college students in the 
United States (see bottom chart on 
previous page). 
Older adults  
Persons aged 65 years and older 
comprise only 13 percent of the 
Older patients are more likely to be prescribed 
long-term and multiple prescriptions, which 
could lead to improper use of medications.
females and about a third were aged 
12 to 17. Although prescription 
drug abuse affects many Americans, 
certain populations, such as youth, 
older adults, and women, may be at 
particular risk. 
Adolescents and young adults 
Abuse of prescription drugs is 
highest among young adults aged 
18 to 25, with 5.9 percent reporting 
nonmedical use in the past month 
(NSDUH, 2010). Among youth 
aged 12 to 17, 3.0 percent reported 
past-month nonmedical use of 
prescription medications. 
According to the 2010 MTF, 
prescription and OTC drugs are 
among the most commonly abused 
drugs by 12th graders (see figure on 
page 6), after alcohol, marijuana, 
and tobacco. While past-year 
nonmedical use of sedatives and 
tranquilizers decreased among 12th 
graders over the last 5 years, this 
is not the case for the nonmedical 
use of amphetamines or opioid pain 
relievers. 
When asked how prescription 
opioids were obtained for 
nonmedical use, more than half of 
the 12th graders surveyed said they 
were given the drugs or bought 
them from a friend or relative. 
Interestingly, the number of students 
who purchased opioids over the 
Internet was negligible (see top chart 
on previous page).
population, yet account for more 
than one-third of total outpatient 
spending on prescription 
medications in the United States. 
Older patients are more likely 
to be prescribed long-term and 
multiple prescriptions, and some 
experience cognitive decline, 
which could lead to improper use 
of medications. Alternatively, 
those on a fixed income may 
abuse another person’s remaining 
medication to save money. 
The high rates of comorbid 
illnesses in older populations, 
age-related changes in drug 
metabolism, and the potential 
for drug interactions may make 
any of these practices more 
dangerous than in younger 
populations. Further, a large 
percentage of older adults also 
use OTC medicines and dietary 
supplements, which (in addition 
to alcohol) could compound any 
adverse health consequences 
resulting from prescription drug 
abuse.
Gender differences   
Overall, more males than females 
abuse prescription drugs in all 
age groups except the youngest 
(aged 12 to 17 years); that is, 
females in this age group exceed 
males in the nonmedical use of 
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Past-Year Nonmedical Use of 
Psychotherapeutics Among Persons 
12 or Older, by Gender and Age Group
Annual averages based on 2002-2005
SOURCE: Cotto, J.H, et al. Gender effects on drug use, abuse, and dependence: An analysis 
of results from the National Survey on Drug Use and Health. Gend Med 7(5):402–413, 2010.
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all psychotherapeutics, including 
pain relievers, tranquilizers, and 
stimulants. Among nonmedical users 
of prescription drugs, females 12 to 
17 years old are also more likely to 
meet abuse or dependence criteria for 
psychotherapeutics (see figure, left).
How many people 
suffer adverse health 
consequences from abusing 
prescription drugs? 
The Drug Abuse Warning Network 
(DAWN), which monitors 
emergency department (ED) visits 
in selected areas across the Nation, 
reported that approximately 1 million 
ED visits in 2009 could be attributed 
to prescription drug abuse. Roughly 
343,000 involved prescription 
opioid pain relievers, a rate more 
than double that of 5 years prior. ED 
visits also more than doubled for 
CNS stimulants, involved in nearly 
22,000 visits in 2009, as well as CNS 
depressants (anxiolytics, sedatives, 
and hypnotics), involved in 363,000 
visits. Of the latter, benzodiazepines 
(e.g., Xanax) comprised the vast 
majority. Rates for a popular 
prescribed non-benzodiazepine sleep 
aid, zolpidem (Ambien), rose from 
roughly 13,000 in 2004 to 29,000 in 
2009. More than half of ED visits 
for prescription drug abuse involved 
multiple drugs.
Preventing and 
recognizing 
prescription 
drug abuse    
The risks for addiction to 
prescription drugs increase when 
they are used in ways other than as 
prescribed (e.g., at higher doses, by 
different routes of administration, 
or combined with alcohol or other 
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drugs). Physicians, their patients, 
and pharmacists all can play a 
role in identifying and preventing 
prescription drug abuse.
Physicians. More than 80 
percent of Americans had contact 
with a healthcare professional 
in the past year, placing doctors 
in a unique position, not only to 
prescribe medications, but also to 
identify abuse (or nonmedical use) 
of prescription drugs and prevent the 
escalation to addiction. By asking 
about all drugs, physicians can 
help their patients recognize that a 
To ensure proper 
medical care, 
patients should 
discuss any and all 
drug use—including 
prescription and 
over-the-counter 
medications—with 
their doctors.
Prescription Drug Monitoring Programs 
allow physicians and pharmacists to 
track prescriptions and help identify 
patients who are “doctor shopping.”
problem exists, set recovery goals, 
and seek appropriate treatment. 
Screening for prescription drug 
abuse can be incorporated into 
routine medical visits. Doctors 
should also take note of rapid 
increases in the amount of 
medication needed or frequent, 
unscheduled refill requests. Doctors 
should be alert to the fact that those 
addicted to prescription drugs may 
engage in “doctor shopping”—
moving from provider to provider—
in an effort to obtain multiple 
prescriptions for the drug(s) they 
abuse. 
Preventing or stopping 
prescription drug abuse is an 
important part of patient care. 
However, healthcare providers 
should not avoid prescribing 
stimulants, CNS depressants, or 
opioid pain relievers if needed. (See 
text box on “Chronic Pain Treatment 
and Addiction” on  
page 13.)
Patients. For their part, patients 
can take steps to ensure that they 
use prescription medications 
appropriately: always follow the 
prescribed directions, be aware of 
potential interactions with other 
drugs, never stop or change a dosing 
regimen without first discussing it 
with a healthcare provider, and never 
use another person’s prescription. In 
addition to describing their medical 
problem, patients should always 
inform their healthcare professionals 
about all the prescriptions, OTC 
medicines, and dietary and herbal 
supplements they are taking, before 
they obtain any other medications. 
Additionally, unused or expired 
medications should be properly 
discarded per U.S. Food and Drug 
Administration (FDA) guidelines 
or at U.S. Drug Enforcement 
Administration collection sites.
Pharmacists. Pharmacists 
dispense medications and can help 
patients understand instructions 
for taking them. By being watchful 
for prescription falsifications 
or alterations, pharmacists can 
serve as the first line of defense in 
recognizing prescription drug abuse. 
Some pharmacies have developed 
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hotlines to alert other pharmacies 
in the region when a fraudulent 
prescription is detected. Moreover, 
prescription drug monitoring 
programs (PDMPs), which require 
physicians and pharmacists to 
log each filled prescription into a 
State database, can assist medical 
professionals in identifying patients 
who are getting prescriptions from 
multiple sources. As of May 2011, 48 
States and 1 territory have enacted 
legislation authorizing PDMPs, 34 of 
which are operational.
Treating 
prescription 
drug addiction  
Years of research have shown 
that addiction to any drug (illicit 
or prescribed) is a brain disease 
that can be treated effectively. 
Treatment must take into account 
the type of drug used and the 
needs of the individual. Successful 
treatment may need to incorporate 
several components, including 
detoxification, counseling, and 
sometimes the use of addiction 
medications. Multiple courses of 
treatment may be needed for the 
patient to make a full recovery. 
The two main categories of drug 
addiction treatment are behavioral 
and pharmacological. Behavioral 
treatments help patients stop drug 
use by teaching them strategies 
to function without drugs, deal 
with cravings, avoid drugs and 
situations that could lead to drug 
use, and handle a relapse should it 
occur. When delivered effectively, 
behavioral treatments, such as 
individual counseling, group or 
family counseling, contingency 
management, and cognitive- 
behavioral therapies, also can help 
patients improve their personal 
relationships and their ability 
to function at work and in the 
community. 
Some addictions, such 
as opioid addiction, can be 
treated with medications. These 
pharmacological treatments counter 
the effects of the drug on the brain 
and behavior, and can be used to 
relieve withdrawal symptoms, help 
overcome drug cravings, or treat 
an overdose. Although a behavioral 
or pharmacological approach alone 
may be sufficient for treating some 
patients, research shows that a 
combined approach may be best. 
Treating addiction to 
prescription opioids 
Several options are available for 
effectively treating prescription 
opioid addiction. These options 
are drawn from research on the 
treatment of heroin addiction and 
include medications (e.g., naltrexone, 
methadone, and buprenorphine) 
as well as behavioral counseling 
approaches. 
Naltrexone is an antagonist 
medication that prevents opioids 
from activating their receptors. It is 
used to treat overdose and addiction, 
although its use for addiction has 
been limited due to poor adherence 
and tolerability by patients. Recently, 
an injectable, long-acting form of 
naltrexone (Vivitrol), originally 
approved for treating alcoholism, has 
also received FDA approval to treat 
opioid addiction (i.e., heroin or other 
opioids). Because its effects last for 
weeks, Vivitrol is ideal for patients 
who do not have ready access to 
healthcare or who struggle with 
taking their medications regularly. 
Methadone is a synthetic opioid 
agonist that eliminates withdrawal 
symptoms and relieves drug cravings 
by acting on the same brain targets as 
other opioids like heroin, morphine, 
and opioid pain medications. It has 
Although a behavioral or pharmacological 
approach alone may be sufficient for 
treating some patients, research shows 
that a combined approach may be best. 
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been used successfully for more than 
40 years to treat heroin addiction, but 
must be dispensed through opioid 
treatment programs. Buprenorphine 
is a partial opioid agonist (i.e., it has 
agonist and antagonist properties), 
which can be prescribed by certified 
physicians in an office setting. Like 
methadone, it can reduce cravings 
and is well tolerated by patients. 
NIDA is supporting research needed 
to determine the effectiveness 
of these medications in treating 
addiction to opioid pain relievers.
Treating addiction to 
CNS depressants 
Patients addicted to barbiturates 
and benzodiazepines should not 
attempt to stop taking them on their 
own. Withdrawal symptoms from 
these drugs can be problematic, 
and—in the case of certain CNS 
depressants—potentially life-
threatening. Research on treating 
barbiturate and benzodiazepine 
addiction is sparse; however, 
addicted patients should undergo 
medically supervised detoxification 
because the dosage they take should 
be gradually tapered. Inpatient 
or outpatient counseling can help 
individuals through this process. 
Cognitive-behavioral therapy, which 
focuses on modifying the patient’s 
thinking, expectations, and behaviors 
while increasing skills for coping 
with various life stressors, also 
has been used successfully to help 
individuals adapt to discontinuing 
benzodiazepines. 
Often barbiturate and 
benzodiazepine abuse occurs in 
conjunction with the abuse of other 
drugs, such as alcohol or cocaine. 
In such cases of polydrug abuse, the 
treatment approach should address 
the multiple addictions. 
Treating addiction to 
prescription stimulants 
Treatment of addiction to 
prescription stimulants, such as 
Adderall and Concerta, is based on 
behavioral therapies used in treating 
cocaine and methamphetamine 
addiction. At this time, there are no 
medications that are FDA-approved 
for treating stimulant addiction. 
Thus, NIDA is supporting research in 
this area. 
Depending on the patient’s 
situation, the first steps in treating 
prescription stimulant addiction 
may be to taper the drug dosage 
and attempt to ease withdrawal 
symptoms. The detoxification 
process could then be followed by 
behavioral therapy. Contingency 
management, for example, uses a 
system that enables patients to earn 
vouchers for drug-free urine tests. 
(These vouchers can be exchanged 
for items that promote healthy 
living.) Cognitive-behavioral therapy 
also may be an effective treatment 
for addressing stimulant addiction. 
Finally, recovery support groups 
may be helpful in conjunction with 
behavioral therapy. 
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Chronic Pain Treatment and Addiction
Healthcare providers have long wrestled with how best to treat patients who suffer from 
chronic pain, roughly 116 million in this country. Their dilemma stems from the potential 
risks involved with long-term treatment, such as the development of drug tolerance (and the 
need for escalating doses), hyperalgesia (increased pain sensitivity), and addiction. Patients 
themselves may even be reluctant to take an opioid medication prescribed to them for fear 
of becoming addicted. Estimates of addiction among chronic pain patients vary widely—from 
about 3 percent to 40 percent. This variability is the result of differences in treatment duration, 
insufficient research on long-term outcomes, and disparate study populations and measures 
used to assess abuse or addiction. 
To mitigate addiction risk, physicians should screen patients for potential risk factors, 
including personal or family history of drug abuse or mental illness. Monitoring patients for 
signs of abuse is also crucial, and yet some indicators can signify multiple conditions, making 
accurate assessment challenging. Early or frequent requests for prescription pain medication 
refills, for example, could represent illness progression, the development of drug tolerance, 
or the emergence of a drug problem. 
The development of effective, nonaddicting pain medications is a public health priority. A 
growing elderly population and an increasing number of injured military only add to the 
urgency of this issue. Researchers are exploring alternative medications that can alleviate 
pain but have less abuse potential. More research is needed to better understand effective 
chronic pain management, including identifying factors that predispose some patients to 
addiction and developing measures to prevent abuse.
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Glossary
Addiction: A chronic, relapsing disease characterized 
by compulsive drug seeking and use, despite serious 
adverse consequences, and by long-lasting changes 
in the brain. 
Agonist: A chemical entity that binds to a receptor 
and activates it, mimicking the action of the natural 
(or abused) substance that binds there. 
Antagonist: A chemical entity that binds to a receptor 
and blocks its activation. Antagonists prevent the 
natural (or abused) substance from activating its 
receptor. 
Barbiturate: A type of CNS depressant prescribed to 
promote sleep (usually in surgical procedures) or as 
an anticonvulsant. 
Benzodiazepine: A type of CNS depressant 
prescribed to relieve anxiety and sleep problems. 
Valium and Xanax are among the most widely 
prescribed medications. 
Buprenorphine: A mixed opiate agonist/antagonist 
medication approved by the FDA in October 2002 for 
the treatment of opioid addiction (e.g., heroin).
Central Nervous System: The brain and spinal cord. 
CNS Depressants: A class of drugs that slow CNS 
function (also called sedatives and tranquilizers), 
some of which are used to treat anxiety and 
sleep disorders; includes barbiturates and 
benzodiazepines. 
Comorbidity: The occurrence of two disorders or 
illnesses in the same person, also referred to as 
co-occurring conditions or dual diagnosis. Patients 
with comorbid illnesses may experience a more 
severe illness course and require treatment for each 
or all conditions.
Detoxification: A process in which the body rids itself 
of a drug (or its metabolites). During this period, 
withdrawal symptoms can emerge that may require 
medical treatment.  This is often the first step in drug 
abuse treatment.
Dopamine: A brain chemical, classified as a 
neurotransmitter, found in regions that regulate 
movement, emotion, motivation, and pleasure. 
Methadone: A long-acting synthetic opioid 
medication that is effective in treating opioid 
addiction and pain.
Narcolepsy: A disorder characterized by 
uncontrollable episodes of deep sleep. 
Norepinephrine: A neurotransmitter present in the 
brain and the peripheral (sympathetic) nervous 
system; and a hormone released by the adrenal 
glands. Norepinephrine is involved in attention, 
responses to stress, and it regulates smooth muscle 
contraction, heart rate, and blood pressure. 
Opioid: A compound or drug that binds to receptors 
in the brain involved in the control of pain and other 
functions (e.g., morphine, heroin, hydrocodone, 
oxycodone). 
Physical Dependence: An adaptive physiological 
state that occurs with regular drug use and results in 
a withdrawal syndrome when drug use is stopped; 
often occurs with tolerance. Physical dependence 
can happen with chronic—even appropriate—use of 
many medications, and by itself does not constitute 
addiction.
Polydrug Abuse:  The abuse of two or more drugs at 
the same time, such as CNS depressants and alcohol. 
Prescription Drug Abuse: The use of a medication 
without a prescription; in a way other than as 
prescribed; or for the experience or feeling elicited. 
This term is used interchangeably with “nonmedical” 
use, a term employed by many of the national 
surveys.
Psychotherapeutics: Drugs that have an effect on the 
function of the brain and that often are used to treat 
psychiatric/neurologic disorders; includes opioids, 
CNS depressants, and stimulants. 
Respiratory Depression: Slowing of respiration 
(breathing) that results in the reduced availability of 
oxygen to vital organs. 
Sedatives: Drugs that suppress anxiety and 
promote sleep; the NSDUH classification includes 
benzodiazepines, barbiturates, and other types of 
CNS depressants. 
Stimulants: A class of drugs that enhances the 
activity of monamines (such as dopamine) in the 
brain, increasing arousal, heart rate, blood pressure, 
and respiration, and decreasing appetite; includes 
some medications used to treat attention-deficit 
hyperactivity disorder (e.g., methylphenidate 
and amphetamines), as well as cocaine and 
methamphetamine. 
Tolerance: A condition in which higher doses of 
a drug are required to produce the same effect 
achieved during initial use; often associated with 
physical dependence.
Tranquilizers: Drugs prescribed to promote sleep or 
reduce anxiety; the NSDUH classification includes 
benzodiazepines, barbiturates, and other types of 
CNS depressants. 
Withdrawal: Symptoms that occur after chronic use 
of a drug is reduced abruptly or stopped. 
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Where can I get further information about  
prescription drug abuse? 
To learn more about prescription 
drugs and other drugs of abuse,  
visit the NIDA Web site at  
www.drugabuse.gov or contact  
the DrugPubs Research 
Dissemination Center at 
877-NIDA-NIH (877-643-2644; 
TTY/TDD: 240-645-0228). 
 
What’s on the NIDA Web Site
• Information on drugs of abuse and 
related health consequences
• NIDA publications, news, and 
events
• Resources for health care 
professionals
• Funding information (including 
program announcements and 
deadlines) 
• International activities 
• Links to related Web sites (access 
to Web sites of many other 
organizations in the field)
NIDA Web Sites
www.drugabuse.gov 
www.teens.drugabuse.gov
www.drugabuse.gov/drugs-abuse/
prescription-drugs-cold-medicines
www.easyread.drugabuse.gov
For Physician Information 
www.drugabuse.gov/nidamed
Other Web Sites
Information on prescription drug 
abuse is also available through the 
following Web site:
• Substance Abuse and Mental 
Health Services Administration 
Health Information Network: 
www.samhsa.gov/shin
